Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Active, not recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

active_not_recruiting267%
unknown133%

Recent Activity

2 active trials
Showing 3 of 3
active_not_recruiting

BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.

NCT06424379
active_not_recruiting

Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death

NCT05446779
unknownnot_applicable

What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy?

NCT03501394

Clinical Trials (3)

Showing 3 of 3 trials
NCT06424379

BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.

Active Not Recruiting
NCT05446779

Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death

Active Not Recruiting
NCT03501394Not Applicable

What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy?

Unknown

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3